Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes
Conclusions:
In this large population-based study, use of DPP-4 inhibitors was not associated with an increased risk of incident rheumatoid arthritis.
Source: Epidemiology - Category: Epidemiology Tags: Pharmacoepidemiology Source Type: research
More News: Allergy & Immunology | Arthritis | Diabetes | Diabetes Type 2 | Endocrinology | Epidemiology | Rheumatoid Arthritis | Rheumatology | Study | UK Health